SpringWorks Therapeutics
Stamford, US · Founded 2019 · Delaware corporation · 3 known investors
Healthtech
Founders & leadership
DS
Daniel S. LynchExecutive
SI
Saqib IslamExecutive
MG
Michael GrecoExecutive
Board
SS
DP
Deval PatrickBoard director
CL
FL
Freda Lewis-HallBoard director
JS
Jeffrey SchwartzBoard director
PK
Peter KeenBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$125M disclosed across 1 round · 2019
▶$125MraisedApr 2019 · 26 investors · Other Health CareRule 506(b)
▶$125MraisedApr 2019 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Freda Lewis-HallDirector
- Stephen SquintoDirector
- Jeffrey SchwartzDirector
- Deval PatrickDirector
- Daniel S. LynchExecutive Officer, Director
- Saqib IslamExecutive Officer, Director
- Michael GrecoExecutive Officer
- Carl L GordonDirector
- Peter KeenDirector
- Offering amount
- $125M
- Amount sold
- $125M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are SpringWorks Therapeutics's investors?
- SpringWorks Therapeutics's investors include Bain Capital Life Sciences, Pfizer Venture Investments, OrbiMed.
- How much funding has SpringWorks Therapeutics raised?
- SpringWorks Therapeutics has disclosed $125M raised across 1 round.
- Where is SpringWorks Therapeutics headquartered?
- SpringWorks Therapeutics is headquartered in Stamford, US.